Aida Habtezion

Aida Habtezion is an Eritrean physician and immunologist. In 2021, Habtezion took a leave of absence from Stanford University to become the Chief Medical Officer of Pfizer and head of Worldwide Medical and Safety within Worldwide Research, Development, and Medicine.

Aida Habtezion
Born
Eritrea
Academic background
EducationBSc, Chemistry, University of Alberta
MSc, University of Guelph
MD, McMaster University
Academic work
InstitutionsStanford University

Early life and education

Habtezion was born in Asmara, Eritrea to Ethiopia Habtezion and Roman Haregot. She is the granddaughter of Dejazmach Haregot Abbai who served as Mayor of Asmara from 1963 until 1974. She completed her Bachelor of Science degree in chemistry from the University of Alberta, her Master of Science in nutritional sciences at the University of Guelph, and her medical degree from McMaster University.[1]

Career

Following her clinical fellowship training, Habtezion obtained postdoctoral research training in Immunology at Stanford University.[1] Habtezion was a fellow in the laboratory of Eugene Butcher where she became interested in ulcerative colitis.[2] Habtezion then joined the faculty at Stanford in 2010 as an assistant professor of medicine.[3] Upon joining the faculty, led her own laboratory which "aims to understand immune mechanisms and identify potential immune-based therapeutic targets for pancreatitis and inflammatory bowel disease."[4] As a result of her research, she was elected a member of the American Society for Clinical Investigation in 2017.[4]

During the COVID-19 pandemic, Habtezion co-authored SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California.[5] In 2021, Habtezion took a leave of absence from Stanford to become the Chief Medical Officer of Pfizer and head of Worldwide Medical and Safety within Worldwide Research, Development, and Medicine.[6]

References
  1. "Aida Habtezion: Board of Governors". New York Academy of Science. Retrieved October 22, 2021.
  2. ""There's a lot more work to be done." – Aida Habtezion". Stanford University. Retrieved October 22, 2021.
  3. "Report of the president: Academic Council Professoriate appointments". Stanford University. February 9, 2011. Retrieved October 22, 2021.
  4. "Aida Habtezion, MD, MSc". American Society for Clinical Investigation. Retrieved October 22, 2021.
  5. Gubatan, John; Levitte, Steven; Balabanis, Tatiana; Patel, Akshar; Sharma, Arpita; Habtezion, Aida (September 2020). "SARS-CoV-2 Testing, Prevalence, and Predictors of COVID-19 in Patients with Inflammatory Bowel Disease in Northern California". Gastroenterology. 159 (3): 1141–1144. doi:10.1053/j.gastro.2020.05.009. PMC 7204754. PMID 32387541.
  6. "Aida Habtezion Taking Leave of Absence to Join Pfizer". Stanford University. 2021. Retrieved October 22, 2021.

Aida Habtezion publications indexed by Google Scholar

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.